Pirkanmaan Erikoislääkäripalvelu, Tampere, Finland.
Drugs Aging. 2009;26(8):703-13. doi: 10.2165/11316470-000000000-00000.
Polyethylene glycol (PEG) is a commonly used osmotic laxative. PEG with electrolytes is mixed with water, but PEG without electrolytes can also be mixed with, for example, juice, coffee or tea, making it more palatable. Laxatives, including PEG, are commonly used by the elderly, particularly those living in institutions. Few clinical studies, however, have investigated the use of PEG in this population.
To test whether PEG 4000 without electrolytes (hypotonic PEG) is at least as effective and safe as PEG 4000 with electrolytes (isotonic PEG) in elderly institutionalized constipated patients. The acceptability of the treatments was also compared.
This randomized, double-blind, parallel-group study was conducted at ten private assisted-living facilities or communal nursing homes in Finland. Eligible patients were required to have used isotonic PEG at a stable dose without any other treatment for constipation (except for Plantago ovata seeds) for at least 2 weeks prior to a run-in period. After the 1-week run-in, 62 patients (mean age 86 years; range 66-99 years) were randomly either switched to receive hypotonic PEG or continued to receive isotonic PEG, both dissolved in water, 12 g once or twice daily or once every other day, for 4 weeks. Stool frequency, stool consistency, stool straining and gastrointestinal symptoms were recorded. Safety laboratory tests were conducted before and after the treatment period. Acceptability was assessed at the end of the study.
At week 4, mean (SD) weekly stool frequencies in the hypotonic and isotonic PEG groups were 8.5 (4.5) and 8.4 (3.6), respectively. The mean stool frequency ratio (95% CI) was 0.90 (0.74, 1.10); thus, the PEG products were considered equally effective. At week 4, the proportion of patients with soft or normal stool consistency was higher in the hypotonic PEG group than in the isotonic PEG group (70% vs 52%), but this difference was not statistically significant. There were no differences between the groups in stool straining or gastrointestinal symptoms. In the safety laboratory tests, no clinically significant differences between the groups were detected, although plasma sodium level was statistically significantly lower in the hypotonic PEG group at the end of the study (137.7 vs 138.9 mmol/L, respectively; p = 0.012). Most patients were willing to continue their study treatment (85% in the hypotonic PEG and 63% in the isotonic PEG group; p = 0.070). Compared with only 12% of the patients receiving hypotonic PEG, however, 31% of the patients in the isotonic PEG group rated the taste of the study treatment as bad or very bad (p = 0.101).
Hypotonic PEG solution is as effective as isotonic PEG in the treatment of constipation in elderly institutionalized patients. Both treatments appear safe, well tolerated and, when dissolved in water, well accepted by the majority of the patients. When desired, switching from isotonic to hypotonic PEG can safely take place in elderly individuals without compromising efficacy.
聚乙二醇(PEG)是一种常用的渗透性泻药。PEG 与电解质混合后可溶于水,但也可以与例如果汁、咖啡或茶混合,使其口感更好。包括 PEG 在内的泻药在老年人中,特别是在养老院居住的老年人中常被使用。然而,很少有临床研究调查 PEG 在这一人群中的使用情况。
测试不含电解质的 PEG 4000(低渗 PEG)与含电解质的 PEG 4000(等渗 PEG)在老年住院便秘患者中的疗效和安全性是否至少相当。还比较了两种治疗方法的可接受性。
这是一项在芬兰 10 家私人辅助生活设施或公共疗养院进行的随机、双盲、平行组研究。合格的患者需要在进行为期 1 周的导入期之前,使用等渗 PEG 稳定剂量治疗至少 2 周,且在此期间未使用其他任何治疗便秘的药物(车前子种子除外)。在导入期结束后,62 名患者(平均年龄 86 岁;范围 66-99 岁)被随机分为两组,一组切换为服用低渗 PEG,另一组继续服用等渗 PEG,均溶于水,每天服用 12 克,每日 1 次或 2 次,或每两天 1 次,持续 4 周。记录每周粪便频率、粪便稠度、排便费力和胃肠道症状。在治疗前后进行安全性实验室检查。在研究结束时评估可接受性。
在第 4 周时,低渗和等渗 PEG 组每周的平均(SD)粪便频率分别为 8.5(4.5)和 8.4(3.6)。PEG 产品的平均粪便频率比值(95%CI)为 0.90(0.74,1.10),因此两种 PEG 产品被认为具有同等疗效。在第 4 周时,低渗 PEG 组中软便或正常便稠度的患者比例高于等渗 PEG 组(70%比 52%),但差异无统计学意义。两组在排便费力或胃肠道症状方面无差异。在安全性实验室检查中,两组均未发现有临床意义的差异,尽管在研究结束时低渗 PEG 组的血浆钠水平有统计学显著降低(分别为 137.7 与 138.9mmol/L;p=0.012)。大多数患者愿意继续接受研究治疗(低渗 PEG 组为 85%,等渗 PEG 组为 63%;p=0.070)。然而,与仅 12%服用低渗 PEG 的患者相比,31%服用等渗 PEG 的患者认为研究治疗的口感较差或非常差(p=0.101)。
低渗 PEG 溶液在治疗老年住院患者便秘方面与等渗 PEG 同样有效。两种治疗方法均安全、耐受良好,且当溶于水时,大多数患者接受度较高。在不影响疗效的情况下,老年患者可以安全地从等渗切换为低渗 PEG。